2026年2月14日, 华尔街Zen将科技、医疗、能源及其他部门的多股股票降级, On February 14, 2026, Wall Street Zen downgraded multiple stocks across tech, healthcare, energy, and other sectors due to growth, valuation, and sector risks.

2026年2月14日,华尔街禅在多个行业的众多股票的评级下调,转移了ACM研究,Aclarion,Allogene Therapeutics和美国资源等公司的评级. On February 14, 2026, Wall Street Zen downgraded numerous stocks across multiple sectors, shifting companies like ACM Research, Aclarion, Allogene Therapeutics, and American Resources to sell ratings. 其他如Alliance Entertainment、AdaptHealth、AMETEK和Blackberry的评级则从强买或买持或卖出下调。 Others, including Alliance Entertainment, AdaptHealth, AMETEK, and Blackberry, were downgraded from strong-buy or buy to hold or sell. 这些变动反映了对增长、估值和具体部门风险的日益关切,影响到技术、医疗保健、能源、金融和消费品方面的公司。 The moves reflect growing concerns over growth, valuation, and sector-specific risks, affecting firms in technology, healthcare, energy, finance, and consumer goods.